Complex EGFR mutations in lung cancer are generally noted through NGS‐based molecular tests and Kohsaka et al. recently reported that almost one‐fifth of NSCLC cases with the EGFR L858R mutation (38/195 cases) actually harbor comutations with other parts of the EGFR gene.10 The gene discussed is EGFR; the disease is lung carcinoma.